Enfusion, Inc. (ENFN) is a publicly traded company in the Unknown sector. Across all available filings, 27 corporate insiders have executed 186 transactions totaling $187.2M, demonstrating a bearish sentiment with -$101.4M in net insider flow. The most recent transaction on Sep 10, 2024 involved a sale of 3,219 shares valued at $26.1K.
No significant insider buying has been recorded for ENFN in the recent period.
No significant insider selling has been recorded for ENFN in the recent period.
Based on recent SEC filings, insider sentiment for ENFN is bearish with an Insider Alignment Score of 23/100 and a net flow of -$101.4M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Enfusion, Inc. (ENFN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 27 insiders are actively trading ENFN stock, having executed 186 transactions in the past 90 days. The most active insider is Bradford E. Bernstein (Executive), who has made 1 transactions totaling $64.8M.
Get notified when executives and directors at ENFN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 10, 2024 | Bastone Bronwen | Executive | Sale | 3,219 | $8.12 | $26.1K | |
| Jun 20, 2024 | Bastone Bronwen | Executive | Sale | 18,241 | $8.11 | $147.9K | |
| Jun 18, 2024 | Bastone Bronwen | Executive | Sale | 10,539 | $8.17 | $86.1K | |
| Jun 18, 2024 | Campobasso Matthew | Executive | Sale | 1,651 | $8.17 | $13.5K | |
| Jun 18, 2024 | Gutowski Valeria | Executive | Sale | 1,258 | $8.17 | $10.3K | |
| Jun 14, 2024 | Somers Deirdre | Executive | Sale | 4,629 | $8.40 | $38.9K | |
| Jun 13, 2024 | E. Leibowitz Lawrence | Executive | Award | 13,470 | $N/A | $0 | |
| Jun 13, 2024 | Derose Kathleen | Executive | Award | 13,470 | $N/A | $0 | |
| Jun 13, 2024 | Hauser Jan | Executive | Award | 13,470 | $N/A | $0 | |
| Jun 13, 2024 | Spellacy Michael | Executive | Award | 13,470 | $N/A | $0 | |
| Jun 13, 2024 | Somers Deirdre | Executive | Award | 13,470 | $N/A | $0 | |
| May 20, 2024 | Bastone Bronwen | Executive | Sale | 34,059 | $9.55 | $325.3K | |
| Mar 5, 2024 | Holdings Llc Csl Tech | Executive | Award | 149,701 | $N/A | $0 | |
| Mar 5, 2024 | Holdings Llc Csl Tech | Executive | Award | 100,000 | $N/A | $0 | |
| Mar 1, 2024 | Bastone Bronwen | Executive | Award | 104,603 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 51 | $144.3M | 72.5% |
Purchase(P) | 4 | $42.9M | 21.5% |
Award(A) | 91 | $9.6M | 4.8% |
Payment(F) | 32 | $2.3M | 1.1% |
Conversion(C) | 6 | $0 | 0.0% |
Other(J) | 2 | $0 | 0.0% |
Insider selling pressure at Enfusion, Inc. has increased, with 27 insiders executing 186 transactions across all time. Total sales of $144.3M significantly outpace purchases of $42.9M, resulting in a net outflow of $101.4M. This selling activity appears largely discretionary, which may warrant closer attention from investors.